Skip to content

DOXYS: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

DOXYS

BE 0890.015.481
NACE 86.995, Nutrition and dietetics services
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€571
2024 · €764-€193
Equity
€23,637
2024 · €23,066+€571
Cash
€32,381
2024 · €3,794+€28,587
Balance sheet total
€35,853
2024 · €35,446+€407

Largest movements

2024 to 2025
Assets
  • Cash +€28,587

    up €28,587 (+753.5%), from €3,794 to €32,381

    mainly Current investments (+€28,000) and Net result for the year (+€571)

  • Current investments -€28,000

    no longer reported in 2025 (was €28,000)

Equity and liabilities
  • Profit (loss) carried forward +€571

    up €571 (+0.4%), from -€151,919 to -€151,348

Income statement
  • Gross operating margin -€433

    down €433 (-31.0%), from €1,395 to €962

  • Financial income +€272

    new in 2025: €272

  • Financial charges +€18

    up €18 (+10.0%), from €180 to €198

  • Other operating charges +€14

    up €14 (+3.1%), from €451 to €465

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €764
Gross operating margin -€433
Other operating charges -€14
Financial income +€272
Financial charges -€18
Result 2025 €571

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€587
Investment +€28,000
Financing €0
Cash 2024 €3,794
Net result for the year +€571
Receivables within one year +€180
Trade debts -€164
Current investments +€28,000
Cash 2025 €32,381
Every line side by side 27 lines
Line Code 2024 2025 Change %
Total assets 20/58 €35,446 €35,853 +€407 +1.1%
Current assets 29/58 €35,446 €35,853 +€407 +1.1%
Amounts receivable within one year 40/41 €3,652 €3,472 -€180 -4.9%
Trade receivables 40 €3,652 €3,472 -€180 -4.9%
Current investments 50/53 €28,000 - -€28,000
Cash at bank and in hand 54/58 €3,794 €32,381 +€28,587 +753.5%
Total equity and liabilities 10/49 €35,446 €35,853 +€407 +1.1%
Equity 10/15 €23,066 €23,637 +€571 +2.5%
Contributions 10/11 €174,985 €174,985 = 0.0%
Capital 10 €174,985 €174,985 = 0.0%
Issued capital 100 €174,985 €174,985 = 0.0%
Profit (loss) carried forward 14 -€151,919 -€151,348 +€571 +0.4%
Amounts payable 17/49 €12,380 €12,216 -€164 -1.3%
Amounts payable within one year 42/48 €12,380 €12,216 -€164 -1.3%
Trade debts 44 €347 €183 -€164 -47.3%
Suppliers 440/4 €347 €183 -€164 -47.3%
Other amounts payable 47/48 €12,033 €12,033 = 0.0%
Other operating charges 640/8 €451 €465 +€14 +3.1%
Gross operating margin 9900 €1,395 €962 -€433 -31.0%
Operating profit (loss) 9901 €944 €497 -€447 -47.4%
Financial income 75/76B - €272 +€272
Recurring financial income 75 - €272 +€272
Financial charges 65/66B €180 €198 +€18 +10.0%
Recurring financial charges 65 €180 €198 +€18 +10.0%
Profit (loss) for the period before taxes 9903 €764 €571 -€193 -25.3%
Profit (loss) for the period 9904 €764 €571 -€193 -25.3%
Profit (loss) for the period to be appropriated 9905 €764 €571 -€193 -25.3%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 11 October 2026 via checked.be.